NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 162 filers reported holding NEVRO CORP in Q4 2018. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $8,599,000 | -5.6% | 61,729 | -61.4% | 0.43% | -30.0% |
| Q3 2018 | $9,109,000 | +186.4% | 159,800 | +356.6% | 0.62% | +42.3% |
| Q3 2017 | $3,181,000 | +113.6% | 35,000 | +75.0% | 0.43% | +113.3% |
| Q2 2017 | $1,489,000 | -83.3% | 20,000 | -78.9% | 0.20% | -88.3% |
| Q1 2017 | $8,902,000 | +104.2% | 95,000 | +58.3% | 1.73% | +86.1% |
| Q4 2016 | $4,360,000 | +4.4% | 60,000 | +50.0% | 0.93% | +35.6% |
| Q3 2016 | $4,176,000 | -24.0% | 40,000 | -46.3% | 0.68% | -31.3% |
| Q2 2016 | $5,495,000 | – | 74,500 | – | 1.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 622,615 | $38,920,000 | 8.04% |
| Tamarack Advisers, LP | 160,000 | $10,002,000 | 3.97% |
| Birch Run Capital Advisors, LP | 187,425 | $11,716,000 | 3.72% |
| Prosight Management, LP | 128,765 | $8,049,000 | 3.52% |
| Ratan Capital Management LP | 38,653 | $2,416,000 | 3.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 579,463 | $36,222,000 | 1.39% |
| Spark Investment Management LLC | 403,400 | $25,216,000 | 1.17% |
| Sivik Global Healthcare LLC | 50,000 | $3,126,000 | 1.15% |
| ArrowMark Colorado Holdings LLC | 1,882,009 | $117,644,000 | 1.11% |
| PFM Health Sciences, LP | 721,229 | $45,084,000 | 1.00% |